At-Home Genital Nerve Stimulation for SCI Bowel
This study is exploring if a treatment called genital nerve stimulation (GNS) can help people with spinal cord injuries (SCI) manage their bowel function. GNS uses a device with small pads placed on the skin near the genitals to deliver electrical stimulation. Researchers want to see if this daily at-home treatment can reduce bowel accidents. You might be able to join if you are 18 or older, have a spinal cord injury, and meet other specific health criteria. The main goal is to see if using GNS every day for 6 weeks is practical and safe.
- Study design
- This study plans to enroll 12 participants. It will compare a target stimulation level to a placebo stimulation level.
- What's involved
- You would use electrical stimulation on the skin in the pelvic area for 6-8 hours each day for 4 weeks at home. You will also visit the research center 3 times for exams and questions, and keep a daily diary.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary goal is measured from baseline to the end of 6 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
At-Home Genital Nerve Stimulation for SCI Bowel
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Kim Anderson, PhD · PRINCIPAL_INVESTIGATOR · MetroHealth System, Ohio
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- The primary endpoint will be the feasibility of daily application of GNS as an intervention for NBD.From baseline to the end of 6 weeks
The 1st feasibility measure bench mark will be the proportion of enrolled who complete the full stimulation protocol.
- The primary endpoint will be the feasibility of daily application of GNS as an intervention for NBD.From baseline to the end of 6 weeks
The 2nd feasibility measure bench mark will be the number of occurrences of unblinding.
- The primary endpoint will be the feasibility of daily application of GNS as an intervention for NBD.From baseline to the end of 6 weeks
The 3rd feasibility measure bench mark will be the retention rate.